Nominated by: Frans Cornelissen, University Medical Center Groningen
Presented by: Alessandro Grillini
Login or Register
You need to be logged in to use this feature.
Falling Walls Venture
Reyedar: Breaking the Wall to Early Detection of Degenerative Diseases
Reyedar
Reyedar’s mission is to democratise access to early diagnosis of life-impairing degenerative diseases. By combining state-of-the-art infra-red eye-tracking powered by Deep Learning, they create accessible medical devices for diagnosing visual impairments, neurological diseases, and cognitive disorders in just a few minutes of non-invasive testing. This unique hardware-software combination is called SONDA (Standardized Oculomotor and Neuro-ophthalmic Disorders Assessment).
SONDA allows for extremely fast, objective, and patient-friendly quantification of eye movement properties and their conversion into a novel diagnostic biomarker. Their first product, SONDA SCREENER, improves the diagnostic workflow of Glaucoma and other severe retinopathies by enabling unprecedentedly fast and simple functional vision testing inside and outside hospitals.
Alessandro Grillini
Reyedar
Alessandro Grillini is the founder, CEO and CTO of Reyedar. He is an award-winning public speaker and a recognized expert in eye-tracking technology. Holding a PhD in Computational Neuroscience, he developed a decade of experience in multidisciplinary contexts involving medicine, engineering, and business. His main areas of expertise are neuro-ophthalmology, psychophysics, biomedical signal processing, and A.I. applications in medical devices.
During his PhD at the University Medical Center Groningen, Alessandro participated in the global Falling Walls Lab Finale in 2019 after winning Falling Walls Lab Groningen with his pitch on Breaking the Wall of Neuro-Visual Diagnosis.